ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
CY1126274T1Undetermined Publication Date: 2026-07-31BERLIN CHEMIE AG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100555T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-03-29
- Filing Date
- 2023-10-11
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2043-10-11
Abstract
The present invention relates to novel combinations of antineoplastic or anticancer agents for the combination treatment of tumors, pharmaceutical compositions intended for combined use and kits containing compositions of different antineoplastic agents for combined use. In particular, the present invention relates to combinations of various antineoplastic agents with the PBK Class I inhibitor 5-(7-methanesulfonyl-2-morpholin-4-yl-6,7-dihydro-5H-pyrrolo[2.3-d]pyrimidin-4-yl)-pyrimidin-2-yl-amine or pharmaceutically acceptable salts thereof.
Need to check novelty before this filing date? Find Prior Art